Investors

Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Recent News

Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors

Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately BUENA, N.J. , Feb. 23, 2021 /PRN...

Learn More

Teligent, Inc. Announces Appointment of William S. Marth to Board of Directors

Generic Pharmaceutical and Contract Manufacturing Industry Leader Joins Teligent Board, Effective Immediately BUENA, N.J...

Learn More

Teligent Takes Strategic Steps to Recapitalize and Position Business for Success

Completes $77 million debt-for-equity exchange with Series C noteholders and senior secured lenders at premiums of 60% a...

Learn More

Investor Overview

There are no items to display.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.